Björn Regland

3.0k total citations
50 papers, 2.3k citations indexed

About

Björn Regland is a scholar working on Rheumatology, Physiology and Psychiatry and Mental health. According to data from OpenAlex, Björn Regland has authored 50 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Rheumatology, 15 papers in Physiology and 14 papers in Psychiatry and Mental health. Recurrent topics in Björn Regland's work include Folate and B Vitamins Research (29 papers), Alzheimer's disease research and treatments (13 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (7 papers). Björn Regland is often cited by papers focused on Folate and B Vitamins Research (29 papers), Alzheimer's disease research and treatments (13 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (7 papers). Björn Regland collaborates with scholars based in Sweden, United Kingdom and Norway. Björn Regland's co-authors include C. G. Gottfries, Kaj Blennow, Martin Lehmann, Carl‐Gerhard Gottfries, C. G. Gottfries, Andrew McCaddon, Peter Hudson, Magnus Sjögren, Gareth Davies and Olof Zachrisson and has published in prestigious journals such as The Lancet, PLoS ONE and Neurology.

In The Last Decade

Björn Regland

50 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Björn Regland Sweden 29 972 652 575 453 287 50 2.3k
Kim A. Jobst United Kingdom 15 889 0.9× 602 0.9× 522 0.9× 303 0.7× 300 1.0× 23 2.5k
Carole Johnston United Kingdom 23 2.1k 2.1× 912 1.4× 442 0.8× 427 0.9× 578 2.0× 29 3.3k
Erland Arning United States 30 1.2k 1.2× 599 0.9× 186 0.3× 948 2.1× 304 1.1× 97 2.7k
Andrew McCaddon United Kingdom 22 1.3k 1.3× 400 0.6× 200 0.3× 434 1.0× 341 1.2× 36 2.0k
Peter Hudson United Kingdom 18 702 0.7× 443 0.7× 146 0.3× 299 0.7× 267 0.9× 41 1.6k
Cristina Sierra Spain 30 229 0.2× 295 0.5× 234 0.4× 561 1.2× 218 0.8× 140 2.6k
Paul Juneau United States 22 390 0.4× 588 0.9× 87 0.2× 475 1.0× 175 0.6× 73 2.2k
İsmail H. Ulus Türkiye 30 181 0.2× 647 1.0× 231 0.4× 738 1.6× 220 0.8× 111 2.7k
Mabel Martelli Italy 13 534 0.5× 368 0.6× 348 0.6× 158 0.3× 147 0.5× 15 1.2k

Countries citing papers authored by Björn Regland

Since Specialization
Citations

This map shows the geographic impact of Björn Regland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Björn Regland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Björn Regland more than expected).

Fields of papers citing papers by Björn Regland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Björn Regland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Björn Regland. The network helps show where Björn Regland may publish in the future.

Co-authorship network of co-authors of Björn Regland

This figure shows the co-authorship network connecting the top 25 collaborators of Björn Regland. A scholar is included among the top collaborators of Björn Regland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Björn Regland. Björn Regland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Regland, Björn & Andrew McCaddon. (2019). Alzheimer’s Amyloidopathy: An Alternative Aspect. Journal of Alzheimer s Disease. 68(2). 483–488. 5 indexed citations
2.
Regland, Björn, L. Abrahamsson, Kaj Blennow, C. G. Gottfries, & Anders Wallin. (2009). Vitamin B12 in CSF: reduced CSF/serum B12 ratio in demented men. Acta Neurologica Scandinavica. 85(4). 276–281. 11 indexed citations
3.
Gottfries, Carl‐Gerhard, et al.. (2006). Long-Term Treatment with aStaphylococcusToxoid Vaccine in Patients with Fibromyalgia and Chronic Fatigue Syndrome. Journal of Chronic Fatigue Syndrome. 13(4). 29–40. 2 indexed citations
4.
Regland, Björn. (2005). Schizophrenia and single-carbon metabolism. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 29(7). 1124–1132. 36 indexed citations
5.
Regland, Björn, et al.. (2004). CSF-methionine is elevated in psychotic patients. Journal of Neural Transmission. 111(5). 631–640. 27 indexed citations
6.
Lehmann, Martin, Björn Regland, Kaj Blennow, & C. G. Gottfries. (2003). Vitamin B<sub>12</sub>-B<sub>6</sub>-Folate Treatment Improves Blood-Brain Barrier Function in Patients with Hyperhomocysteinaemia and Mild Cognitive Impairment. Dementia and Geriatric Cognitive Disorders. 16(3). 145–150. 75 indexed citations
7.
McCaddon, Andrew, et al.. (2003). Alzheimer’s disease and total plasma aminothiols. Biological Psychiatry. 53(3). 254–260. 75 indexed citations
8.
Zachrisson, Olof, et al.. (2002). Treatment with staphylococcus toxoid in fibromyalgia/chronic fatigue syndrome—a randomised controlled trial. European Journal of Pain. 6(6). 455–466. 32 indexed citations
9.
McCaddon, Andrew, et al.. (2001). Analogues, Ageing and Aberrant Assimilation of Vitamin B12 in Alzheimer’s Disease. Dementia and Geriatric Cognitive Disorders. 12(2). 133–137. 15 indexed citations
10.
Wallin, Anders, Magnus Sjögren, Åke Edman, K. Blennow, & Björn Regland. (2000). Symptoms, Vascular Risk Factors and Blood-Brain Barrier Function in Relation to CT White-Matter Changes in Dementia. European Neurology. 44(4). 229–235. 78 indexed citations
11.
Smythies, John, Carl‐Gerhard Gottfries, & Björn Regland. (1997). Disturbances of one-carbon metabolism in neuropsychiatric disorders: A review. Biological Psychiatry. 41(2). 230–233. 37 indexed citations
12.
Landén, Mikael, Camilla Hesse, Pam Fredman, et al.. (1996). Apolipoprotein E in Cerebrospinal Fluid from Patients with Alzheimer's Disease and Other Forms of Dementia Is Reduced but without Any Correlation to the apoE4 Isoform. Dementia and Geriatric Cognitive Disorders. 7(5). 273–278. 46 indexed citations
13.
Regland, Björn, et al.. (1995). Homocysteinemia is a common feature of schizophrenia. Journal of Neural Transmission. 100(2). 165–169. 86 indexed citations
14.
Regland, Björn, et al.. (1995). Decreased methionine adenosyltransferase activity in erythrocytes of patients with dementia disorders. European Neuropsychopharmacology. 5(2). 107–114. 26 indexed citations
15.
McCaddon, Andrew, Björn Regland, & Christopher Fear. (1995). Trypsin inhibition: A potential cause of cobalamin deficiency common to the pathogenesis of Alzheimer-type dementia and AIDS dementia complex?. Medical Hypotheses. 45(2). 200–204. 5 indexed citations
16.
Gottfries, C. G., Jan Balldin, Kaj Blennow, et al.. (1994). Regulation of the Hypothalamic‐Pituitary‐Adrenal Axis in Dementia Disorders. Annals of the New York Academy of Sciences. 746(1). 336–343. 29 indexed citations
17.
Balldin, Jan, Kaj Blennow, Görel Bråne, et al.. (1994). Relationship between Mental Impairment and HPA Axis Activity in Dementia Disorders. Dementia and Geriatric Cognitive Disorders. 5(5). 252–256. 12 indexed citations
18.
Regland, Björn & C. G. Gottfries. (1992). [Vitamin B 12 deficiency--even a neuropsychiatric problem].. PubMed. 89(35). 2736–40. 1 indexed citations
19.
Regland, Björn & C. G. Gottfries. (1992). Slowed synthesis of DNA and methionine is a pathogenetic mechanism common to dementia in down's syndrome, AIDS and Alzheimer's disease?. Medical Hypotheses. 38(1). 11–19. 28 indexed citations
20.
Regland, Björn, L. Abrahamsson, C. G. Gottfries, & Erik M. Magnus. (1990). Vitamin B<sub>12</sub> Analogues, Homocysteine, Methylmalonic Acid, and Transcobalamins in the Study of Vitamin B<sub>12</sub> Deficiency in Primary Degenerative Dementia. Dementia and Geriatric Cognitive Disorders. 1(5). 272–277. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kim A. Jobst Breakdown of academic impact, for papers by Carole Johnston Breakdown of academic impact, for papers by Erland Arning Breakdown of academic impact, for papers by Andrew McCaddon Breakdown of academic impact, for papers by Peter Hudson Breakdown of academic impact, for papers by Cristina Sierra Breakdown of academic impact, for papers by Paul Juneau Breakdown of academic impact, for papers by İsmail H. Ulus Breakdown of academic impact, for papers by Mabel Martelli
Rankless by CCL
2026